LINC02656: A Potential Drug Target and Biomarker (G399716)

Target Name: LINC02656

NCBI ID: G399716

LINC02656

Other Name(s): Uncharacterized protein DKFZp667F0711 | long intergenic non-protein coding RNA 2656 | Long intergenic non-protein coding RNA 2656 | DKFZp667F0711

LINC02656: A Potential Drug Target and Biomarker

Introduction

LINC02656 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases.

Structure and Function

LINC02656 is a protein that is expressed in various tissues and cells in the body, including the brain, heart, liver, and muscle. Its primary function is to regulate the activity of the protein tyrosine kinase (TK), which is a critical enzyme involved in cell signaling. LINC02656 is a type of protein known as a non-coding RNA-protein hybrid, which means it consists of a non-coding RNA that can interact with a protein.

The structure of LINC02656 is unique and has been studied extensively. It has a characteristic 伪-helical shape and a distinct N-terminus that is rich in conserved amino acid sequence. The C-terminus of LINC02656 is also distinct and contains a conserved glycine residue, which is important for its stability and function.

LINC02656 has been shown to play a critical role in various cellular processes, including cell signaling, DNA replication, and cell growth. Its expression has been associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Potential Drug Target

LINC02656 is a potential drug target due to its unique structure and function. Its N-terminus is rich in conserved amino acids, which may make it an attractive target for small molecules that can modulate its activity. Additionally, its 伪-helical shape and distinct C-terminus may make it vulnerable to certain types of drugs that can disrupt its stability or function.

LINC02656 has been shown to play a critical role in cell signaling, which is a key aspect of many diseases. For example, LINC02656 has been shown to be involved in the regulation of the activity of the protein tyrosine kinase (TK), which is involved in the development and progression of cancer. Additionally, LINC02656 has been shown to be involved in the regulation of cell growth and the maintenance of stem cell properties.

Potential Biomarkers

LINC02656 may also be a potential biomarker for various diseases. Its unique structure and function make it an attractive target for diagnostic assays, such as mass spectrometry-based assays or affinity purification assays. Additionally, its expression may be affected by various diseases, which could make it a useful biomarker for disease diagnosis and monitoring.

Conclusion

LINC02656 is a protein that has potential as a drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for small molecules that can modulate its activity. Additionally, its expression has been associated with various diseases, which could make it a useful biomarker for disease diagnosis and monitoring. Further research is needed to fully understand its role in these diseases and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 2656

The "LINC02656 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02656 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets